World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
40535
World Ranking
8851
National Ranking
25

Overview

George V. Papatheodoridis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily focuses on Medicine, with extensive work in the subfields of Epidemiology, Hepatology, Surgery, Genetics, and Infectious Diseases.

Their scholarly output covers major topics such as Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation, Liver Diseases and Immunity, Inflammatory Bowel Disease, and Hepatitis Viruses Studies and Epidemiology.

Recent publications include the following papers:

  • Hepatitis B, 2023, The Lancet
  • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis, 2020, Journal of Hepatology
  • Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis, 2021, Journal of Hepatology
  • COVID-19 pandemic and worldwide organ transplantation: a population-based study, 2021, The Lancet Public Health
  • EASL Clinical Practice Guidelines on hepatitis delta virus, 2023, Journal of Hepatology

George V. Papatheodoridis frequently collaborates with the following co-authors:

  • Μargarita Papatheodoridi
  • Spilios Manolakopoulos
  • Εvangelos Cholongitas
  • Jiannis Vlachogiannakos
  • Marı́a Buti

The scientist publishes regularly in prominent journals, including:

  • Journal of Hepatology
  • Liver International
  • Gastroenterology
  • Journal of Viral Hepatitis
  • Clinical Gastroenterology and Hepatology

Best Publications

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

    George V. Papatheodoridis;Henry Lik Yuen Chan;Bettina E. Hansen;Harry L A Janssen;Harry L A Janssen

  • Efficacy of long‐term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B

    Stephanos J. Hadziyannis;George V. Papatheodoridis;Evangelini Dimou;Andreas Laras

  • Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

    E. Cholongitas;G. V. Papatheodoridis;M. Vangeli;N. Terreni

  • Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

    George V. Papatheodoridis;Pietro Lampertico;Spilios Manolakopoulos;Anna Lok

  • PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    George Papatheodoridis;George Dalekos;Vana Sypsa;Cihan Yurdaydin

  • Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

    George V. Papatheodoridis;John Goulis;Gioacchino Leandro;David Patch

  • Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

    Edward Gane;Eric Lawitz;David Pugatch;Georgios Papatheodoridis

  • The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B

    George V Papatheodoridis;Emanuel Manesis;Stephanos J Hadziyannis

  • Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

    Yun-Fan Liaw;I-Shyan Sheen;Chuan-Mo Lee;Ulus Salih Akarca

  • Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    Patrick Marcellin;Sang Hoon Ahn;Xiaoli Ma;Florin A. Caruntu

  • The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

    A. Hatzakis;S. Wait;J. Bruix;M. Buti

  • Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

    Stephanos J. Hadziyannis;George V. Papatheodoridis

  • Liver grafts from anti-hepatitis B core positive donors: a systematic review.

    Evangelos Cholongitas;George V. Papatheodoridis;Andrew K. Burroughs

  • The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

    George V. Papatheodoridis;Ramazan Idilman;George N. Dalekos;Maria Buti

  • Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    Homie Razavi;Sarah Robbins;Stefan Zeuzem;Francesco Negro

Frequent Co-Authors

Stephanos J. Hadziyannis
Stephanos J. Hadziyannis National and Kapodistrian University of Athens
Angelos Hatzakis
Angelos Hatzakis National and Kapodistrian University of Athens
Emmanuel Tsochatzis
Emmanuel Tsochatzis University College London
Pietro Lampertico
Pietro Lampertico University of Milan
Maria Buti
Maria Buti Instituto de Salud Carlos III
Andrew K. Burroughs
Andrew K. Burroughs University College London
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
Brian R. Davidson
Brian R. Davidson University College London
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not set on the lengthy path of a traditional MD, there are flexible alternatives to consider. Nursing is a growing field with several online degree options that allow you to start or advance your career without relocating.

For those seeking quick entry into the profession, direct admit nursing programs make it easier for aspiring nurses to begin training right after high school. If you’re already a registered nurse, enrolling in one of the most affordable accredited online rn to bsn programs can boost your credentials and career potential with a flexible learning schedule.

Non-nurses who hold a bachelor’s degree in another field can transition to advanced roles through online direct entry msn programs, which fast-track you to a master’s in nursing. For those who aim for leadership, research, or teaching roles in healthcare, phd in nursing online programs offer the highest academic qualification with the convenience of remote study.

Exploring these pathways can open new doors in medicine and streamline your journey toward a fulfilling career in healthcare.

Best Scientists Citing George V. Papatheodoridis

Trending Scientists

Recently Published Articles